ArticleBiochemical pharmacology2012
The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II.
Brian B Hasinoff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it